The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Bronchiectasis is a clinical and radiological diagnosis associated with cough, sputum production and recurrent respiratory infections. The clinical presentation inevitably overlaps with other respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). In addition, 4–72% of patients with severe COPD are found to have radiological bronchiectasis on computed tomography, with similar frequencies (20–30%) now being reported in cohorts with severe or uncontrolled asthma. Co-diagnosis of bronchiectasis with another airway disease is associated with increased lung inflammation, frequent exacerbations, worse lung function and higher mortality. In addition, many patients with all three disorders have chronic rhinosinusitis and upper airway disease, resulting in a complex “mixed airway” phenotype. The management of asthma, bronchiectasis, COPD and upper airway diseases has traditionally been outlined in separate guidelines for each individual disorder. Recognition that the majority of patients have one or more overlapping pathologies requires that we re-evaluate how we treat airway disease. The concept of treatable traits promotes a holistic, pathophysiology-based approach to treatment rather than a syndromic approach and may be more appropriate for patients with overlapping features. Here, we review the current clinical definition, diagnosis, management and future directions for the overlap between bronchiectasis and other airway diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fokkens, W. J., Lund, V. J., Mullol, J., Bachert, C., Alobid, I., Baroody, F., Cohen, N., Cervin, A., Douglas, R., Gevaert, P., et al. (2012) · Rhinology journal · doi:10.4193/rhino12.000 · Cited by 2,387
Characterisation of COPD heterogeneity in the ECLIPSE cohort
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-122 · Cited by 1,157 · cited 1×
“…2009 [53] Hospitalised COPD (previous BCH were excluded) 88 72.1±10 95 Incidence and risk factors for PA <2 affected segments were considered normal 52 AGUSTI et al., 2010 [54] ECLIPSE cohort of GOLD II–IV stable COPD (previous BCH were excluded) 2164 63.4±7.1 65 Characterisation of COPD…”
BackgroundInfluentialThe bronchiectasis severity index. An international derivation and validation study
Chalmers, J. D., Goeminne, P., Aliberti, S., McDonnell, M. J., Lonni, S., Davidson, J., Poppelwell, L., Salih, W., Pesci, A., Dupont, L. J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1575oc · Cited by 1,093
Self-citationMultidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score
Martínez-García, M. Á., de Gracia, J., Vendrell Relat, M., Girón, R.-M., Máiz Carro, L., de la Rosa Carrillo, D., & Olveira, C. (2014) · European Respiratory Journal · doi:10.1183/09031936.00026313 · Cited by 503 · cited 1×
“…2012 [58] Stable COPD GOLD II–IV COPDGene 3752 62.8–65.5§ 55 Prevalence and clinical impact of BCH Visual assessment 20.8 GOLD II: 18.8 GOLD III: 24 GOLD IV: 24 MARTÍNEZ-GARCÍA et al., 2013 [59] Stable moderate-to-severe COPD (previous BCH were excluded) 201 70.3±8.9 90.5 Prognostic value…”
BackgroundInfluentialSelf-citationCo‐morbidities in severe asthma: Clinical impact and management
Porsbjerg, C., & Menzies‐Gow, A. (2017) · Respirology · doi:10.1111/resp.13026 · Cited by 233
Allergic Bronchopulmonary Aspergillosis
Greenberger, P. A., Bush, R. K., Demain, J. G., Luong, A., Slavin, R. G., & Knutsen, A. P. (2014) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2014.08.007 · Cited by 167
Cited by
Chalmers, J. D., Polverino, E., Crichton, M. L., Ringshausen, F. C., De Soyza, A., Vendrell, M., Burgel, P. R., Haworth, C. S., Loebinger, M. R., Dimakou, K., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00093-0 · Cited by 315
Self-citationLung imaging in COPD and asthma
Tanabe, N., Nakagawa, H., Sakao, S., Ohno, Y., Shimizu, K., Nakamura, H., Hanaoka, M., Nakano, Y., & Hirai, T. (2024) · Respiratory Investigation · doi:10.1016/j.resinv.2024.08.014 · Cited by 21
Metadata
- Authors
- Polverino, E., Dimakou, K., Hurst, J., Martinez-Garcia, M.-A., Miravitlles, M., Paggiaro, P., Shteinberg, M., Aliberti, S., & Chalmers, J. D.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2018-07-26
- Volume
- 52
- Issue
- 3
- Pages
- 1800328
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2884457464
- Cited by
- 242
- References
- 6
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. https://app.cochat.ai/papers/10.1183/13993003.00328-2018
- The paper
- Polverino, E., Dimakou, K., Hurst, J., Martinez-Garcia, M.-A., Miravitlles, M., Paggiaro, P., Shteinberg, M., Aliberti, S., & Chalmers, J. D. (2018). The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. European Respiratory Journal. https://doi.org/10.1183/13993003.00328-2018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.